Diagnostic value of 68 Ga-DOTATATE PET-CT imaging for staging of ER+ /PR+ HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and 18 F-FDG PET-CT in a prospective pilot trial.

Andrew NguyenKaren FullardGemma Sheehan-DareReuben TangLyn ChanBao HoRachel DearJoanne KeaneAdam HickeyRohan NandurkarJulia ChenAndrew ChenElgene LimLouise Emmett

Published in: Journal of medical imaging and radiation oncology (2021)

Whilst we have not demonstrated DOTA to be superior to FDG in staging of ER+ /PR+ breast cancers, DOTA may have a role in assessing HR status and treatment decisions; further evaluation of this is warranted.

Keyphrases

pet ct
positron emission tomography
high resolution
computed tomography
endoplasmic reticulum
estrogen receptor
breast cancer cells
dual energy
bone mineral density
magnetic resonance imaging
magnetic resonance
young adults
pet imaging
postmenopausal women